Identificazione di cellule con caratteristiche staminali in meningiomi umani quali possibili indicatori di comportamento clinico atipico in tumori istologicamente benigni

B Roncan - 2020 - unire.unige.it
Il meningioma è il tumore intracranico primitivo più frequente, prevalentemente classificato
come grado I dall'OMS. Tuttavia, il 20% dei meningiomi recidiva o subisce trasformazione …

[PDF][PDF] Long-term outcome of operated intracranial meningioma patients in Tampere University Hospital

L Jaatinen - 2020 - trepo.tuni.fi
Meningiomas are the second most common intracranial tumours after metastases and the
most common primary intracranial neoplasms for adults accounting for 13-26% of all primary …

Investigating the role of TAM (TYRO3, AXL and MERTK) family receptors in Merlin-deficient tumours

F Dave - 2020 - pearl.plymouth.ac.uk
Mutations in the NF2 gene, which codes for the tumour suppressor Merlin, is responsible for
the development of all Neurofibromatosis Type 2 (NF2)-related tumours including …

[PDF][PDF] Tropical Journal of Pathology and Microbiology

JP Patel, DK Goel, PP Trivedi… - Tropical Journal of …, 2020 - pdfs.semanticscholar.org
Introduction: Meningiomas are tumors that arise from the meningothelial cells. They are
commonly located at intracranial, intraspinal or occasionally ectopic site. They show …

Utjecaj izmjene Ei N-kadherina na fosforilacijski status beta-katenina i epitelno-mezenhimsku tranziciju u intrakranijalnim meningeomima

A Bukovac - 2020 - dr.nsk.hr
Sažetak Epitelno-mezenhimska tranzicija (EMT) koju karakterizira kadherinska izmjena,
odnosno smanjena ekspresija E-kadherina, a pojačana N-kadherina, ima važnu ulogu u …

良性脳腫瘍に対するゲノム診断とゲノム医療

吉本幸司 - 脳神経外科ジャーナル, 2020 - jstage.jst.go.jp
抄録 良性脳腫瘍である頭蓋咽頭腫, 髄膜腫, 神経鞘腫について, ゲノム診断とゲノム医療への応用
の可能性について現状を解説した. 乳頭頭蓋咽頭腫型では BRAF 遺伝子の V600E …